BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 25008556)

  • 1. Osteoclasts: more than 'bone eaters'.
    Charles JF; Aliprantis AO
    Trends Mol Med; 2014 Aug; 20(8):449-59. PubMed ID: 25008556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of Wnt signals in bone resorption during physiological and pathological states.
    Maeda K; Takahashi N; Kobayashi Y
    J Mol Med (Berl); 2013 Jan; 91(1):15-23. PubMed ID: 23111637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
    Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
    J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between osteoblast and osteoclast: impact in bone disease.
    Phan TC; Xu J; Zheng MH
    Histol Histopathol; 2004 Oct; 19(4):1325-44. PubMed ID: 15375775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70.
    Garbe AI; Roscher A; Schüler C; Lutter AH; Glösmann M; Bernhardt R; Chopin M; Hempel U; Hofbauer LC; Rammelt S; Egerbacher M; Erben RG; Jessberger R
    J Bone Miner Res; 2012 Oct; 27(10):2085-96. PubMed ID: 22648978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation.
    Thudium CS; Moscatelli I; Flores C; Thomsen JS; Brüel A; Gudmann NS; Hauge EM; Karsdal MA; Richter J; Henriksen K
    Calcif Tissue Int; 2014 Jul; 95(1):83-93. PubMed ID: 24838599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ClC-7 expression levels critically regulate bone turnover, but not gastric acid secretion.
    Supanchart C; Wartosch L; Schlack C; Kühnisch J; Felsenberg D; Fuhrmann JC; de Vernejoul MC; Jentsch TJ; Kornak U
    Bone; 2014 Jan; 58():92-102. PubMed ID: 24103576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimuli and Relevant Signaling Cascades for NFATc1 in Bone Cell Homeostasis: Friend or Foe?
    Zhang Z; Wen H; Yang X; Zhang K; He B; Zhang X; Kong L
    Curr Stem Cell Res Ther; 2019; 14(3):239-243. PubMed ID: 30516111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The loss of STAT3 in mature osteoclasts has detrimental effects on bone structure.
    Davidson RK; Himes ER; Takigawa S; Chen A; Horn MR; Meijome T; Wallace JM; Kacena MA; Yokota H; Nguyen AV; Li J
    PLoS One; 2020; 15(7):e0236891. PubMed ID: 32730332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
    Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Sasaki T; Hatano H; Hotta T; Endo N
    PLoS One; 2016; 11(5):e0154680. PubMed ID: 27163152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoclasts have multiple roles in bone in addition to bone resorption.
    Boyce BF; Yao Z; Xing L
    Crit Rev Eukaryot Gene Expr; 2009; 19(3):171-80. PubMed ID: 19883363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are nonresorbing osteoclasts sources of bone anabolic activity?
    Karsdal MA; Martin TJ; Bollerslev J; Christiansen C; Henriksen K
    J Bone Miner Res; 2007 Apr; 22(4):487-94. PubMed ID: 17227224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.
    Chu K; Snyder R; Econs MJ
    J Bone Miner Res; 2006 Jul; 21(7):1089-97. PubMed ID: 16813529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopetrosis--multiple pathways for the interception of osteoclast function.
    Marks SC
    Appl Pathol; 1987; 5(3):172-83. PubMed ID: 3304355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe developmental bone phenotype in ClC-7 deficient mice.
    Neutzsky-Wulff AV; Sims NA; Supanchart C; Kornak U; Felsenberg D; Poulton IJ; Martin TJ; Karsdal MA; Henriksen K
    Dev Biol; 2010 Aug; 344(2):1001-10. PubMed ID: 20599900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.
    Okayasu M; Nakayachi M; Hayashida C; Ito J; Kaneda T; Masuhara M; Suda N; Sato T; Hakeda Y
    J Biol Chem; 2012 Jun; 287(23):19229-41. PubMed ID: 22500026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.
    Miyauchi Y; Ninomiya K; Miyamoto H; Sakamoto A; Iwasaki R; Hoshi H; Miyamoto K; Hao W; Yoshida S; Morioka H; Chiba K; Kato S; Tokuhisa T; Saitou M; Toyama Y; Suda T; Miyamoto T
    J Exp Med; 2010 Apr; 207(4):751-62. PubMed ID: 20368579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of FGFR3 in Osteoclast Lineage Cells Results in Increased Bone Mass in Mice by Inhibiting Osteoclastic Bone Resorption.
    Su N; Li X; Tang Y; Yang J; Wen X; Guo J; Tang J; Du X; Chen L
    J Bone Miner Res; 2016 Sep; 31(9):1676-87. PubMed ID: 26990430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Imaging: Osteoclast and Osteoblast Dynamics.
    Kikuta J; Ishii M
    Methods Mol Biol; 2018; 1763():1-9. PubMed ID: 29476483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder.
    Sugatani T
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.